Imagine spending thousands of dollars on weight-loss medication—only to discover months later that it doesn't work for your ...

The Medicare GLP-1 Bridge may hold the key to Eli Lilly's market share.

At-home health testing platform Ash is expanding its partnership with weight-loss company Noom to bring Noom's Proactive Health Microdose GLP-1Rx Program to market. Noom's program, launched in August, ...

Wondering why your GLP-1 medication isn't working? Discover the most common reasons weight loss stalls on Ozempic, Wegovy, ...

Ozempic was supposed to be a gut story. Then Allison Shapiro looked at the brain scans. An assistant professor at the University of Colorado Anschutz, she was part of a team studying 13 teens and ...

Medicare's new GLP-1 Bridge program offers eligible beneficiaries Wegovy, Zepbound, or Foundayo for $50 a month starting July ...

The enormous popularity of new weight-loss drugs often eclipses the downsides: the burden of weekly injections, rough gastrointestinal side effects, muscle and bone loss. That is shaping a race among ...

A weight-loss medication eased Serena Williams’s comeback. Experts can’t agree on whether that counts as doping.

After months of successful weight loss, Eshaan Jain's progress had halted after switching to Wegovy. The food noise instantly came back after switching from Zepbound to Wegovy during a ...